Titre : Bacillus megaterium

Bacillus megaterium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit and Disruptive Behavior Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bacillus megaterium : Questions médicales les plus fréquentes", "headline": "Bacillus megaterium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bacillus megaterium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-01", "dateModified": "2025-03-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bacillus megaterium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bacillus", "url": "https://questionsmedicales.fr/mesh/D001407", "about": { "@type": "MedicalCondition", "name": "Bacillus", "code": { "@type": "MedicalCode", "code": "D001407", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.510.460.410.158.218" } } }, "about": { "@type": "MedicalCondition", "name": "Bacillus megaterium", "alternateName": "Bacillus megaterium", "code": { "@type": "MedicalCode", "code": "D001410", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rita Bernhardt", "url": "https://questionsmedicales.fr/author/Rita%20Bernhardt", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Campus B2.2, 66123, Saarland University, Saarbrücken, Germany." } }, { "@type": "Person", "name": "Subbi Rami Reddy Tadi", "url": "https://questionsmedicales.fr/author/Subbi%20Rami%20Reddy%20Tadi", "affiliation": { "@type": "Organization", "name": "Bioprocess Analytical Technology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India." } }, { "@type": "Person", "name": "Senthilkumar Sivaprakasam", "url": "https://questionsmedicales.fr/author/Senthilkumar%20Sivaprakasam", "affiliation": { "@type": "Organization", "name": "Bioprocess Analytical Technology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India. senthilkumar@iitg.ac.in." } }, { "@type": "Person", "name": "Philip Hartz", "url": "https://questionsmedicales.fr/author/Philip%20Hartz", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Campus B2.2, 66123, Saarland University, Saarbrücken, Germany." } }, { "@type": "Person", "name": "Ganesh Nehru", "url": "https://questionsmedicales.fr/author/Ganesh%20Nehru", "affiliation": { "@type": "Organization", "name": "Bioprocess Analytical Technology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Parent training for disruptive behavior symptoms in attention deficit hyperactivity disorder: a randomized clinical trial.", "datePublished": "2024-02-16", "url": "https://questionsmedicales.fr/article/38434955", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyg.2024.1293244" } }, { "@type": "ScholarlyArticle", "name": "Attention deficit hyperactivity and oppositional defiant disorder symptoms in adolescence and risk of substance use disorders-A general population-based birth cohort study.", "datePublished": "2023-07-11", "url": "https://questionsmedicales.fr/article/37431766", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/acps.13588" } }, { "@type": "ScholarlyArticle", "name": "Parental Efficacy in Managing Smartphone Use of Adolescents with Attention-Deficit/Hyperactivity Disorder: Parental and Adolescent Related Factors.", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35954859", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19159505" } }, { "@type": "ScholarlyArticle", "name": "Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study.", "datePublished": "2024-10-15", "url": "https://questionsmedicales.fr/article/39400201", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DBP.0000000000001323" } }, { "@type": "ScholarlyArticle", "name": "Some critical considerations in applying the construct of psychopathy to research and classification of childhood disruptive behavior disorders.", "datePublished": "2022-07-21", "url": "https://questionsmedicales.fr/article/35878505", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cpr.2022.102188" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Bactéries à Gram positif", "item": "https://questionsmedicales.fr/mesh/D006094" }, { "@type": "ListItem", "position": 4, "name": "Bâtonnets à Gram positif", "item": "https://questionsmedicales.fr/mesh/D016987" }, { "@type": "ListItem", "position": 5, "name": "Bâtonnets sporulés à Gram positif", "item": "https://questionsmedicales.fr/mesh/D016937" }, { "@type": "ListItem", "position": 6, "name": "Bacillaceae", "item": "https://questionsmedicales.fr/mesh/D001406" }, { "@type": "ListItem", "position": 7, "name": "Bacillus", "item": "https://questionsmedicales.fr/mesh/D001407" }, { "@type": "ListItem", "position": 8, "name": "Bacillus megaterium", "item": "https://questionsmedicales.fr/mesh/D001410" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bacillus megaterium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bacillus megaterium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bacillus megaterium", "description": "Comment diagnostiquer une infection par Bacillus megaterium ?\nQuels tests sont utilisés pour identifier Bacillus megaterium ?\nBacillus megaterium est-il pathogène pour l'homme ?\nQuels échantillons sont nécessaires pour le diagnostic ?\nY a-t-il des signes cliniques associés à Bacillus megaterium ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bacillus megaterium", "description": "Quels symptômes sont associés à une infection par Bacillus megaterium ?\nBacillus megaterium provoque-t-il des symptômes spécifiques ?\nLes infections par Bacillus megaterium sont-elles asymptomatiques ?\nComment les symptômes évoluent-ils avec Bacillus megaterium ?\nY a-t-il des symptômes généraux à surveiller ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bacillus megaterium", "description": "Comment prévenir les infections par Bacillus megaterium ?\nY a-t-il des vaccins contre Bacillus megaterium ?\nQuelles mesures de sécurité en laboratoire sont nécessaires ?\nLes personnes à risque doivent-elles prendre des précautions ?\nComment gérer les déchets biologiques contenant Bacillus megaterium ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bacillus megaterium", "description": "Quel traitement est recommandé pour une infection par Bacillus megaterium ?\nLes infections par Bacillus megaterium nécessitent-elles une hospitalisation ?\nY a-t-il des traitements préventifs pour Bacillus megaterium ?\nComment gérer les infections graves par Bacillus megaterium ?\nLes antibiotiques sont-ils toujours efficaces contre Bacillus megaterium ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bacillus megaterium", "description": "Quelles complications peuvent survenir avec Bacillus megaterium ?\nLes infections par Bacillus megaterium peuvent-elles être mortelles ?\nComment prévenir les complications liées à Bacillus megaterium ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles plus fréquentes chez certains groupes ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bacillus megaterium", "description": "Quels sont les facteurs de risque d'infection par Bacillus megaterium ?\nLes personnes âgées sont-elles plus à risque ?\nLes patients hospitalisés sont-ils plus vulnérables ?\nL'exposition professionnelle augmente-t-elle le risque ?\nLes maladies chroniques influencent-elles le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D001410?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Bacillus megaterium ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par culture bactérienne et identification en laboratoire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Bacillus megaterium ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques et des techniques de séquençage génétique sont utilisés." } }, { "@type": "Question", "name": "Bacillus megaterium est-il pathogène pour l'homme ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement non pathogène, mais peut causer des infections opportunistes." } }, { "@type": "Question", "name": "Quels échantillons sont nécessaires pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de tissus ou de liquides corporels peuvent être analysés." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques associés à Bacillus megaterium ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes peuvent inclure fièvre et inflammation, selon le site d'infection." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une infection par Bacillus megaterium ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure fièvre, douleurs et signes d'infection locale." } }, { "@type": "Question", "name": "Bacillus megaterium provoque-t-il des symptômes spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes varient selon l'individu et le site d'infection." } }, { "@type": "Question", "name": "Les infections par Bacillus megaterium sont-elles asymptomatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec Bacillus megaterium ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver rapidement, nécessitant une attention médicale." } }, { "@type": "Question", "name": "Y a-t-il des symptômes généraux à surveiller ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez la fièvre, la fatigue et les douleurs, surtout après exposition." } }, { "@type": "Question", "name": "Comment prévenir les infections par Bacillus megaterium ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter l'exposition à des environnements contaminés." } }, { "@type": "Question", "name": "Y a-t-il des vaccins contre Bacillus megaterium ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin spécifique pour Bacillus megaterium." } }, { "@type": "Question", "name": "Quelles mesures de sécurité en laboratoire sont nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles prendre des précautions ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées doivent éviter les environnements à risque." } }, { "@type": "Question", "name": "Comment gérer les déchets biologiques contenant Bacillus megaterium ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être stérilisés et éliminés selon les réglementations en vigueur." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour une infection par Bacillus megaterium ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques peuvent être prescrits, selon la sensibilité de la souche." } }, { "@type": "Question", "name": "Les infections par Bacillus megaterium nécessitent-elles une hospitalisation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité de l'infection et de l'état de santé du patient." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs pour Bacillus megaterium ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement préventif spécifique, mais l'hygiène est essentielle." } }, { "@type": "Question", "name": "Comment gérer les infections graves par Bacillus megaterium ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les infections graves nécessitent des soins intensifs et un suivi médical étroit." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours efficaces contre Bacillus megaterium ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, car certaines souches peuvent développer une résistance aux antibiotiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Bacillus megaterium ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections systémiques et des septicémies." } }, { "@type": "Question", "name": "Les infections par Bacillus megaterium peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, surtout chez les patients immunodéprimés, elles peuvent être fatales." } }, { "@type": "Question", "name": "Comment prévenir les complications liées à Bacillus megaterium ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic précoce et un traitement approprié sont essentiels pour prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications à long terme sont rares mais peuvent inclure des problèmes respiratoires." } }, { "@type": "Question", "name": "Les complications sont-elles plus fréquentes chez certains groupes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et immunodéprimées sont plus à risque de complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection par Bacillus megaterium ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, les interventions chirurgicales et l'exposition en laboratoire." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque d'infection." } }, { "@type": "Question", "name": "Les patients hospitalisés sont-ils plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients hospitalisés, surtout ceux en soins intensifs, sont plus vulnérables." } }, { "@type": "Question", "name": "L'exposition professionnelle augmente-t-elle le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de laboratoire et de santé sont à risque accru d'infection." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques peuvent affaiblir le système immunitaire et augmenter le risque." } } ] } ] }

Sources (10000 au total)

Parent training for disruptive behavior symptoms in attention deficit hyperactivity disorder: a randomized clinical trial.

Attention-Deficit/Hyperactivity Disorder (ADHD) affects 5% of children and 2.5% of adults worldwide. Comorbidities are frequent, and Oppositional Defiant Disorder (ODD) reaches 50%. Family environment... A clinical trial was designed to compare PT-online and face-to-face effects to a waiting list group. Outcomes were the ADHD and ODD symptoms, parental stress and styles, and quality of life. Families ... Parent training was effective in reducing symptoms of ADHD (...

Attention deficit hyperactivity and oppositional defiant disorder symptoms in adolescence and risk of substance use disorders-A general population-based birth cohort study.

Externalizing symptoms are associated with risk of future substance use disorder (SUD). Few longitudinal studies exist using general population-based samples which assess the spectrum of attention def... We aimed to study the associations between adolescent ADHD symptoms and subsequent SUD and additionally examine whether the risk of SUD is influenced by comorbid oppositional defiant disorder (ODD) sy... The Northern Finland Birth Cohort 1986 was linked to nationwide health care register data for incident SUD diagnoses until age 33 years (n = 6278, 49.5% male). ADHD/ODD-case status at age 16 years was... In all, 552 participants (8.8%) presented with ADHD case status at the age of 16 years, and 154/6278 (2.5%) were diagnosed with SUD during the follow-up. ADHD case status was associated with SUD durin... ADHD in adolescence was associated with incident SUD in those with and without symptoms of ODD. The association of ADHD and SUD persisted even after adjustment for a wide range of potential confounds....

Parental Efficacy in Managing Smartphone Use of Adolescents with Attention-Deficit/Hyperactivity Disorder: Parental and Adolescent Related Factors.

Parental management has an important role in preventing problematic smartphone use among adolescents with attention-deficit/hyperactivity disorder (ADHD). This study aimed to examine the parental fact...

Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study.

To examine whether maternal cannabis use during early pregnancy is associated with offspring attention deficit hyperactivity disorder (ADHD) and disruptive behavior disorders (DBD).... We conducted a population-based retrospective birth cohort study of children (N = 141,570) born between 2011 and 2018 to pregnant individuals (N = 117,130) in Kaiser Permanente Northern California uni... The sample of pregnant individuals was 27.2% Asian/Pacific Islander, 5.7% Black, 24.5% Hispanic, and 38.8% non-Hispanic White, with a mean (SD) age of 30.9 (5.2) years; 4.6% screened positive for any ... Maternal prenatal cannabis use was not associated with an increased risk of offspring ADHD or DBD....

Some critical considerations in applying the construct of psychopathy to research and classification of childhood disruptive behavior disorders.

The recent inclusion of callous-unemotional traits in the diagnostic criteria for serious conduct problems has led to renewed interest in more comprehensive integrations of the construct of psychopath...

Attention deficit and hyperactivity disorder disrupts selective mechanisms of action.

People with attention deficit and hyperactivity disorder (ADHD) present attentional and emotional deficits and show paradoxical qualities such as hyperfocus. Previous studies have reported errors, slo... Thirty French children and teenagers, 15 with ADHD and 15 neurotypical (NT), underwent a saccadic eye movement task. We conducted conventional analysis (movement duration, precision, velocity, RT) and... Saccade duration and velocity failed to differentiate the two groups, whereas amplitude was higher in ADHD than in NT participants. Saccade RT and variability were higher in ADHD than in NT participan... ADHD disrupts two mechanisms of action: it reduces the gain of the decision signal, thus explaining slowness and variability; it quickens the decision process of early responses at the origin of short... These premises and their interconnections explain previous observations and support the striatal-frontal wiring of ADHD, thus explaining ADHD complexity in its negative and positive manifestations....

Clinico-Demographic Profile of Children and Adolescents with Attention Deficit Hyperactivity Disorder Presenting to a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children. ADHD leads to significant impairment in overall functioning of the child. There is limited informat... This study retrospectively examines the records of children diagnosed with ADHD at the Child and Adolescent Psychiatry (CAP) Unit, Kanti Children's Hospital (KCH), Nepal. Approval for the study was gr... A total of 585 children were diagnosed with ADHD, with a mean age 7±3.04 years. The majority 501 (85.64%) were male, and 377 (64.44%) were from the school going age group (6 to 11 years). The prevalen... The study indicates that ADHD is highly prevalent in Nepal. Comorbidities like ASD and ID are frequently seen which further necessitates the need for structured assessments and multidisciplinary appro...

Treatment of childhood disruptive behavior disorders and callous-unemotional traits: a systematic review and two multilevel meta-analyses.

Children with callous-unemotional (CU) traits are at high lifetime risk of antisocial behavior. It is unknown if treatments for disruptive behavior disorders are as effective for children with CU trai... We systematically searched PsycINFO, PubMed, Cochran Library (Trials), EMBASE, MEDLINE, APA PsycNet, Scopus, and Web of Science. Eligible studies were randomized controlled trials, controlled trials, ... Sixty studies with 9,405 participants were included (M... DBD+CU children improve with treatment, but their greater DBD symptom severity requires specialized treatment modules that could be implemented alongside parenting programs. Conclusions are tempered b...